Literature DB >> 1980711

Mannose-sensitive haemagglutination in the absence of piliation in Escherichia coli.

S J Hultgren1, J L Duncan, A J Schaeffer, S K Amundsen.   

Abstract

The relationship between type 1 pilus structure and the mannose-sensitive adhesin was investigated by analysing the properties of an 11.2 kb fragment of DNA derived from the chromosomal pil region of a type 1 piliated uropathogenic strain of Escherichia coli. The recombinant plasmids pHA9 and pSJH9, containing the cloned fragment, conferred a mannose-sensitive haemagglutination (MSHA)-positive but non-piliated phenotype on recipient cells of ORN104. Most of the DNA sequences homologous to the pilA and hyp genes were not present in the 11.2 kb insert, and the genetic information necessary for MSHA in the absence of piliation spanned a 6.5 kb region of the cloned fragment. The polypeptides expressed by pSJH9 were examined in minicells and Tn1000 insertions in three genes encoding proteins of molecular weights 90 kD, 29 kD and 17 kD abolished the MSHA phenotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980711     DOI: 10.1111/j.1365-2958.1990.tb00710.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  13 in total

1.  PapD-like chaperones provide the missing information for folding of pilin proteins.

Authors:  M M Barnhart; J S Pinkner; G E Soto; F G Sauer; S Langermann; G Waksman; C Frieden; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli.

Authors:  William R Schwan; Jeffrey L Lee; Farrah A Lenard; Brian T Matthews; Michael T Beck
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Chaperone-subunit-usher interactions required for donor strand exchange during bacterial pilus assembly.

Authors:  Michelle M Barnhart; Frederic G Sauer; Jerome S Pinkner; Scott J Hultgren
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

4.  Structure-based drug design and optimization of mannoside bacterial FimH antagonists.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Robert Obermann; William Nolan; Scott A Wildman; Doug Hobbs; Tom Ellenberger; Corinne K Cusumano; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

5.  The two-component response regulator RcsB regulates type 1 piliation in Escherichia coli.

Authors:  William R Schwan; Satoshi Shibata; Shin-Ichi Aizawa; Alan J Wolfe
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

6.  Role of Mrx fimbriae of Xenorhabdus nematophila in competitive colonization of the nematode host.

Authors:  Holly Snyder; Hongjun He; Heather Owen; Chris Hanna; Steven Forst
Journal:  Appl Environ Microbiol       Date:  2011-08-19       Impact factor: 4.792

7.  Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.

Authors:  Corinne K Garofalo; Thomas M Hooton; Steven M Martin; Walter E Stamm; Joseph J Palermo; Jeffrey I Gordon; Scott J Hultgren
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

8.  FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria.

Authors:  C H Jones; J S Pinkner; A V Nicholes; L N Slonim; S N Abraham; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae.

Authors:  C H Jones; J S Pinkner; R Roth; J Heuser; A V Nicholes; S N Abraham; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

10.  Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins.

Authors:  B Madison; I Ofek; S Clegg; S N Abraham
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.